-
GLOBAL CORD ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Global Cord Blood Corporation and Encourages Investors to Contact the Firm
26 Apr 2024 01:00 GMT
… Cellenkos"), a biotechnology company based in Houston … the Cayman Islands, Financial Services Division, opposing … shareholder knowledge. On this news, Global Cord's stock … investors Global Cord's approach to capital allocation, strategic investments …
-
Fountain Asset Corp. Announces Its Financial Results for the Quarter and Year Ended December 31, 2023
25 Apr 2024 21:44 GMT
… foreign exchange loss of $0.01 million and stock … Company and its shareholders. The Company continued … portfolio investments and capitalizing on investment opportunities … manufacturing, retail, financial services, and biotechnology. Forward-Looking Statements …
-
ARCA biopharma Announces First Quarter 2024 Financial Results and Provides Corporate Update
25 Apr 2024 20:15 GMT
ARCA biopharma and Oruka Therapeutics announce Merger Agreement
ARCA biopharma appoints Thomas Keuer as President
WESTMINSTER, Colo., April 25, 2024 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), (the “Company”) a biopharmaceutical company …
-
Stevanato Group to Report First Quarter 2024 Financial Results on May 9, 2024
25 Apr 2024 20:12 GMT
… NYSE: STVN), a leading global provider of drug containment, … biotechnology, and life sciences industries, announced today that it will issue financial … on the Company’s Investor Relations section of its … Group is a leading global provider of drug containment, …
-
Bioprocess Validation Market Size, Top Companies, Share, Growth And Forecast 2033 | CAGR 5.5%
25 Apr 2024 19:13 GMT
… the changing investment landscape within the global bioprocess validation … biopharmaceutical companies are investing in comprehensive validation … : Pharmaceutical & Biotechnology Companies and Contract Development … Size (Sales) Market Share by Type (Product …
-
Global Food and Grocery Retail Market Foresees to rise at an expected CAGR of 3.3% until 2034, FMI Analysis | Future Market Insights, Inc.
25 Apr 2024 17:30 GMT
NEWARK, Del, April 25, 2024 (GLOBE NEWSWIRE) -- The current valuation of the food and grocery retail market is US$ 12.4 trillion by 2024. The market valuation is estimated to be US$ 17.1 trillion by 2034, projected at a CAGR of 3.3%.
Growing awareness …
-
Global Pulmonary Drugs Market is Expected to Showcase a Significant Growth by 2030, Predicts DelveInsight | Key Companies - F. Hoffmann-La Roche, AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Sanofi, Grifols, Regeneron
25 Apr 2024 17:00 GMT
New York, USA, April 25, 2024 (GLOBE NEWSWIRE) -- Global Pulmonary Drugs Market is Expected to Showcase a Significant Growth by 2030, Predicts DelveInsight | Key Companies - F. Hoffmann-La Roche, AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Sanofi, …
-
Median Technologies Reports Full-year 2023 Financial Results and Provides First Quarter 2024 Financial Information
25 Apr 2024 16:04 GMT
… granted by the European Investment Bank (EIB) in … attract strong interest from biotechnology and pharmaceutical companies, … 47;mediantechnologies.com/investors/financial-results-and-reports/ … property, changes in foreign exchange rates and interest …
-
3 Millionaire-Maker Biotech Stocks
25 Apr 2024 15:18 GMT
… board market.
As veteran investors can attest, however, … biotechnology business can often be an all-or-nothing proposition.
Given investment … is nearly twice Viking stock';s current price. … and underaddressed pharmacological markets. It just takes the …
-
South Korea to Pursue Global Dominance in AI Chip, Advanced Bio, and Quantum Technologies, States Government
25 Apr 2024 15:16 GMT
For the advanced biotechnology industry, the country will focus on fostering digital biotechnologies that connect data, AI and biology, and securing synthetic biology technologies, including DNA and RNA design, protein design and genetic circuit control. ( …